Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Armin AL Olama a et al. |
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
|
|
2 |
Eeles R et al. |
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
|
|
3 |
Hakala T et al. |
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.
|
|
4 |
Heervä E et al. |
Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.
|
|
5 |
Häkkinen M et al. |
Analysis of free, mono- and diacetylated polyamines from human urine by LC-MS/MS.
|
|
6 |
Hämäläinen M et al. |
Dexamethasone-eluting Vascular Stents.
|
|
7 |
Kellokumpu-Lehtinen P, Tammela T. |
Uusilla lääkkeillä parempaa hoitoa eturauhassyöpään.
|
|
8 |
Kilpeläinen T et al. |
Prostate cancer mortality in the Finnish randomized screening trial.
|
|
9 |
Kleber ME et al. |
Genome-Wide Association Study Identifies 3 Genomic Loci Significantly Associated With Serum Levels of Homoarginine: The AtheroRemo Consortium.
|
|
10 |
Kosola J et al. |
Elevated concentration of oxidized LDL together with poor cardiorespiratory and abdominal muscle fitness predicts metabolic syndrome in young men.
|
|
11 |
Kranse R et al. |
Excess all-cause mortality in the evaluation of a screening trial to account for selective participation.
|
|
12 |
Laitinen V et al. |
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
|
|
13 |
Laukontaus S et al. |
Onko vatsa-aortan aneurysman seulontaan aihetta Suomessa?
|
|
14 |
Lehmusvaara S et al. |
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
|
|
15 |
Leinonen KA et al. |
Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer.
|
|
16 |
Linnakoski I et al. |
Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease.
|
|
17 |
Liuhanen S et al. |
Indirect measurement of the vascular endothelial glycocalyx layer thickness in human submucosal capillaries with a plug-in for ImageJ.
|
|
18 |
Markus HS et al. |
Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis.
|
|
19 |
Melkas S et al. |
Aivojen pienten suonten tauti.
|
|
20 |
Murtola TJ et al. |
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5a-reductase inhibitors and alpha-blockers.
|
|
21 |
Mäkelä KM et al. |
Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium.
|
|
22 |
Nurminen R et al. |
Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
|
|
23 |
Oksala N et al. |
Association of Neuroimmune Guidance Cue Netrin-1 and Its Chemorepulsive Receptor UNC5B With Atherosclerotic Plaque Expression Signatures and Stability in Human(s): Tampere Vascular Study (TVS).
|
|
24 |
Oksala N et al. |
Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
|
|
25 |
Pöyhönen A et al. |
Empirical evaluation of grouping of lower urinary tract symptoms: principal component analysis of Tampere Ageing Male Urological Study data.
|
|
26 |
Raitoharju E et al. |
MicroRNAs in the atherosclerotic plaque.
|
|
27 |
Raitoharju E et al. |
A comparison of the accuracy of Illumina HumanHT-12 v3 Expression BeadChip and TaqMan qRT-PCR gene expression results in patient samples from the Tampere Vascular Study.
|
|
28 |
Rantanen T et al. |
CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.
|
|
29 |
Rantanen T et al. |
Reflux symptoms and side effects among patients with gastroesophageal reflux disease at baseline, during treatment with PPIs, and after Nissen fundoplication.
|
|
30 |
Renko J et al. |
Bacterial DNA signatures in carotid atherosclerosis represent both commensals and pathogens of skin origin.
|
|
31 |
Saarinen J. |
Laskimoperäinen turvotus.
|
|
32 |
Salonen A et al. |
Reply from Authors re: Nicolas Mottet. Intermittent Androgen Deprivation in Prostate Cancer: Is Everything So Clear? Eur Urol 2013;63:121-2 Intermittent Androgen Deprivation in Advanced Prostate Cancer: An Optional Treatment Regimen.
|
|
33 |
Salonen AJ et al. |
Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.
|
|
34 |
Salonen AJ et al. |
Reply from Autors re: Nicolas Mottet: Intermittent Androgen-deprivation in Prostate Cancer.
|
|
35 |
Schröder F et al. |
Reply from Authors re: Behfar Ehdaie, Karim A Touijer. 5-Alpha reductase inhibitors in prostate cancer.
|
|
36 |
Schröder F et al. |
Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled Avodart After ...
|
|
37 |
Sciarra A et al. |
Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.
|
|
38 |
Sibolt G et al. |
Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke.
|
|
39 |
Sibolt G et al. |
Poststroke dementia is associated with recurrent ischaemic stroke.
|
|
40 |
Simpson C et al. |
Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.
|
|
41 |
Suominen V et al. |
Fenestrated and chimney endografts for juxtarenal aneurysms: early and midterm results.
|
|
42 |
Tammela TLJ. |
Editorial comment: Treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
|
|
43 |
van Leeuwen Pj et al. |
Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.
|
|
44 |
Vasarainen H et al. |
Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).
|
|
45 |
Vaughan C et al. |
Impact of obesity on urinary storage symptoms: results from the FINNO study.
|
|
46 |
Veitonmäki T et al. |
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
|
|
47 |
Venojärvi M et al. |
Stress proteins and heat shock proteins role in muscle building and sports nutrition.
|
|
48 |
Xu J et al. |
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
|
|
49 |
Yli-Hemminki TH et al. |
Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
|